Vanderbilt Vaccine Center

Vanderbilt and Human Vaccines Project launch initial studies to decode the human immune system

Researchers at Vanderbilt University Medical Center this month began recruiting volunteers to participate in a clinical trial aimed at decoding the human “immunome,” the genetic underpinnings of the immune system.

HIV cell

Potent HIV antibodies suggest new vaccine development approach

It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks.

Media efforts during 2014 Ebola outbreak lauded

Vanderbilt University Medical Center’s Office of News and Communications has received national recognition for its efforts to educate and inform the general public during the 2014 Ebola virus disease outbreak that sparked fear across the nation and around the world.

Vanderbilt researchers identify potential antibody treatment for H7 avian flu

Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.

Antibodies may be ‘silver bullet’ for Ebola viruses

There may be a “silver bullet” for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years.

Year in Review 2015: Achievements, milestones abound at VUMC

The following is a roundup of the news that made headlines at Vanderbilt University Medical Center in 2015.

1 8 9 10 11 12 14